At Biolog-id, our mission is to develop and implement innovative solutions that digitally transform routine processes into actionable data supporting better operational, medical and strategic decisions for sensitive therapeutic products.
“ The company’s vision, endorsed by all Biolog-id’s teams, is to be a trusted global partner for the digital transformation of healthcare. ”
Jean-Claude Mongrenier is a Doctor of Pharmacy. He is an alumnus of the IAE Caen and the London Business School, where he earned his MBA.
Before founding Biolog-id in 2005, he had a series of posts in Sales & Marketing and general management for major American healthcare groups (Baxter, Dupont de Nemours, Johnson&Johnson, Chiron).
Between 2005 and 2016, he expanded the company according to his own vision: using RFID technology to manage and trace sensitive medical products.
In 2016, himself becoming the Founder and Chairman of the Board.
Bruno Chappert is a Senior Executive who is successful at devising strategies that create efficiencies, facilitate sustainable growth, and drive profitability across diverse environments.
During his international career, including the United States (Thales, IBM, Thomson, IN Groupe, etc.), he held various management responsibilities in the areas of Technology Development, Systems Integration, Supply Chains management and Business Units General Management.
In the last ten years, Bruno played a key role in IN Groupe by setting up Digital Services in the area of Identification, Authentication, and Traceability and specifically led strategic key programs supporting the Health sector’s Digital Transformation.
Amit Mayer now has over 20 years of experience in innovation impact across multiple companies, industries, and geographical areas.
Over his career, he held a variety of executive roles in innovation, marketing, instructional design, and analytics. His background includes global experience in several healthcare verticals including pharmaceuticals, chemotherapy, and personalized medicine.
In 2018, he joined Biolog-id as General Manager of the US affiliate, then as VP Innovation & Analytics before taking on the role of Group CIO in 2021.
Valérie Declèves, Chief Revenue Officer, covers Sales for EMEA for the Transfusion, Oncology and Preclinical markets.
She is also responsible for sales administration and EMEA Customer Care activities.
In addition, Valérie is responsible for the Sales business processes and their monitoring, by adapting or developing new reporting and forecasting tools.
Valérie recently held several similar positions within IN Groupe for more than 10 years, with operational and strategic responsibilities. Previously, Valérie held various functions in Operations (Engineering, Supply Chain) and as Consultant; she was also an Entrepreneur by creating and leading a thermal services structure.
Biolog-id founded
Change of governance and new sales strategy /
ISO 9001V2015 certified
Scientific and technical research completed
1 new subsidiary: India (Delhi)
1 new subsidiary: India (Delhi)
Our first products go on sale / ISO 9001V2008 certified
Biolog-id founded
Scientific and technical research completed
Our first products go on sale / ISO 9001V2008 certified
Change of governance and new sales strategy / ISO 9001V2015 certified
Medical device certification for the smart storage kits
1 new subsidiary: India (Delhi)
Please select your location from the liste below so we can display your market content.